Combination of Rapamycin and Imatinib in Treating Refractory Chronic Myeloid Leukemia Myeloid Blast Crisis:a Case Report<sup>025B3;</sup>

Your Location：

Home >

Browse articles >

Combination of Rapamycin and Imatinib in Treating Refractory Chronic Myeloid Leukemia Myeloid Blast Crisis:a Case Report^025B3;

中国医学科学杂志（英文版） 2013年第2期页码：127-128

• Case Report • | Updated：2024-04-10

- Combination of Rapamycin and Imatinib in Treating Refractory Chronic Myeloid Leukemia Myeloid Blast Crisis:a Case Report^025B3;
- Affiliations：
  
  1. Key Laboratory of Thrombosis and Hemostasis of Ministry of Health
  2. Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University,Suzhou,China,215006
- Author bio：
- Funds：
- DOI：
  中图分类号：
- 网络出版日期：2013-06-26，
  
  纸质出版日期：2013
- Accepted：
Scan QR Code
Jing Xie, Xiang Zhang, Bao-zhi Fang, 等. Combination of Rapamycin and Imatinib in Treating Refractory Chronic Myeloid Leukemia Myeloid Blast Crisis:a Case Report^025B3;[J]. 中国医学科学杂志（英文版）, 2013,(2):127-128.

Jing Xie, Xiang Zhang, Bao-zhi Fang, et al. Combination of Rapamycin and Imatinib in Treating Refractory Chronic Myeloid Leukemia Myeloid Blast Crisis:a Case Report^025B3;[J]. Null, 2013, (2): 127-128.
Jing Xie, Xiang Zhang, Bao-zhi Fang, 等. Combination of Rapamycin and Imatinib in Treating Refractory Chronic Myeloid Leukemia Myeloid Blast Crisis:a Case Report^025B3;[J]. 中国医学科学杂志（英文版）, 2013,(2):127-128. DOI：

Jing Xie, Xiang Zhang, Bao-zhi Fang, et al. Combination of Rapamycin and Imatinib in Treating Refractory Chronic Myeloid Leukemia Myeloid Blast Crisis:a Case Report^025B3;[J]. Null, 2013, (2): 127-128. DOI：

Supported by Key Provincial Talents Program of Jiangsu (H201126)

and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).

浏览量

883

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

关联资源

暂无数据

Combination of Rapamycin and Imatinib in Treating Refractory Chronic Myeloid Leukemia Myeloid Blast Crisis:a Case Report025B3;